RepCOOL: computational drug repositioning via integrating heterogeneous biological networks
Abstract Background It often takes more than 10 years and costs more than 1 billion dollars to develop a new drug for a particular disease and bring it to the market. Drug repositioning can significantly reduce costs and time in drug development. Recently, computational drug repositioning attracted...
Main Authors: | Ghazale Fahimian, Javad Zahiri, Seyed Shahriar Arab, Reza H. Sajedi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02541-3 |
Similar Items
-
Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning
by: Yoonbee Kim, et al.
Published: (2022-10-01) -
Predicting Drug–Gene–Disease Associations by Tensor Decomposition for Network-Based Computational Drug Repositioning
by: Yoonbee Kim, et al.
Published: (2023-07-01) -
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
by: Tamer N. Jarada, et al.
Published: (2020-07-01) -
Drug repositioning based on individual bi-random walks on a heterogeneous network
by: Yuehui Wang, et al.
Published: (2019-12-01) -
Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
by: Shimei Qin, et al.
Published: (2023-01-01)